Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Tablets for Hepatitis C Virus Genotype 1 Infection
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Tablets for Hepatitis C Virus Genotype 1 Infection
Authors
Keywords
-
Journal
ANNALS OF PHARMACOTHERAPY
Volume 49, Issue 5, Pages 566-581
Publisher
SAGE Publications
Online
2015-02-14
DOI
10.1177/1060028015570729
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacokinetics, Safety and Tolerability of Cyclosporine or Tacrolimus Following Coadministration of ABT-450/r, ABT-267 and ABT-333 in Healthy Subjects.
- (2017) P. Badri et al. TRANSPLANTATION
- ABT-450: A Novel Protease Inhibitor for the Treatment of Hepatitis C Virus Infection
- (2014) Ivan Gentile et al. CURRENT MEDICINAL CHEMISTRY
- ABT-450, Ritonavir, Ombitasvir, and Dasabuvir Achieves 97% and 100% Sustained Virologic Response With or Without Ribavirin in Treatment-Experienced Patients With HCV Genotype 1b Infection
- (2014) Pietro Andreone et al. GASTROENTEROLOGY
- Liver disease progression in hepatitis C virus carriers with normal alanine aminotransferase levels
- (2014) Claudio Puoti et al. HEPATOLOGY
- Sofosbuvir and Ribavirin for Hepatitis C in Patients With HIV Coinfection
- (2014) Mark S. Sulkowski et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Discovery of ABT-267, a Pan-Genotypic Inhibitor of HCV NS5A
- (2014) David A. DeGoey et al. JOURNAL OF MEDICINAL CHEMISTRY
- Importance of HCV genotype 1 subtypes for drug resistance and response to therapy
- (2014) D. L. Wyles et al. JOURNAL OF VIRAL HEPATITIS
- Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin
- (2014) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin
- (2014) Jordan J. Feld et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
- (2014) Nezam Afdhal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection
- (2014) Nezam Afdhal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis
- (2014) Kris V. Kowdley et al. NEW ENGLAND JOURNAL OF MEDICINE
- ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV
- (2014) Peter Ferenci et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 2b Trial of Interferon-free Therapy for Hepatitis C Virus Genotype 1
- (2014) Kris V. Kowdley et al. NEW ENGLAND JOURNAL OF MEDICINE
- ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis
- (2014) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hepatitis C virus NS5A inhibitors and drug resistance mutations
- (2014) Shingo Nakamoto WORLD JOURNAL OF GASTROENTEROLOGY
- Exploratory Study of Oral Combination Antiviral Therapy for Hepatitis C
- (2013) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
- (2013) Eric Lawitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- 867 IN VITRO COMBINATORY EFFECT OF HCV NS3/4A PROTEASE INHIBITOR ABT-450, NS5A INHIBITOR ABT-267, AND NON-NUCLEOSIDE NS5B POLYMERASE INHIBITOR ABT-333
- (2012) T. Pilot-Matias et al. JOURNAL OF HEPATOLOGY
- 1186 SAFETY AND ANTIVIRAL ACTIVITY OF ABT-267, A NOVEL NS5A INHIBITOR, DURING 3-DAY MONOTHERAPY: FIRST STUDY IN HCV GENOTYPE-1 (GT1)-INFECTED TREATMENT-NAIVE SUBJECTS
- (2012) E. Lawitz et al. JOURNAL OF HEPATOLOGY
- An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases
- (2011) Marc G. Ghany et al. HEPATOLOGY
- 1204 PHARMACOKINETICS, SAFETY AND TOLERABILITY OF THE HCV NS5A INHIBITOR ABT-267 FOLLOWING SINGLE AND MULTIPLE DOSES IN HEALTHY ADULT VOLUNTEERS
- (2011) E.O. Dumas et al. JOURNAL OF HEPATOLOGY
- 1229 GENOTYPIC AND PHENOTYPIC CHARACTERIZATION OF NS3 VARIANTS SELECTED IN HCV-INFECTED PATIENTS TREATED WITH ABT-450
- (2011) T. Pilot-Matias et al. JOURNAL OF HEPATOLOGY
- Hepatitis C virus resistance to protease inhibitors
- (2011) Philippe Halfon et al. JOURNAL OF HEPATOLOGY
- Boceprevir for Untreated Chronic HCV Genotype 1 Infection
- (2011) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection
- (2011) Kenneth E. Sherman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
- (2011) Bruce R. Bacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
- (2011) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Institute of Medicine recommendations for the prevention and control of hepatitis B and C
- (2010) Abigail E. Mitchell et al. HEPATOLOGY
- 1019 PHARMACOKINETICS OF THE HCV POLYMERASE INHIBITOR ABT-333 IN US AND JAPANESE HEALTHY VOLUNTEERS
- (2010) R. Menon et al. JOURNAL OF HEPATOLOGY
- 762 RESISTANCE PROFILE OF ABT-333 AND RELATIONSHIP TO VIRAL LOAD DECREASE IN PATIENTS TREATED IN COMBINATION WITH PEG-INTERFERON AND RIBAVIRIN FOR 28 DAYS
- (2010) T. Middleton et al. JOURNAL OF HEPATOLOGY
- The natural history of recurrent hepatitis C and what influences this
- (2010) Edward J. Gane LIVER TRANSPLANTATION
- Rapid Emergence of Protease Inhibitor Resistance in Hepatitis C Virus
- (2010) L. Rong et al. Science Translational Medicine
- Inhibitors of the Hepatitis C Virus RNA-Dependent RNA Polymerase NS5B
- (2010) Megan H. Powdrill et al. Viruses-Basel
- 957 PHARMACOKINETICS, SAFETY AND TOLERABILITY OF THE HCV POLYMERASE INHIBITOR ABT-333 FOLLOWING MULTIPLE ASCENDING DOSES AND EFFECT OF CO-ADMINISTRATION OF KETOCONAZOLE IN HEALTHY SUBJECTS
- (2009) R. Menon et al. JOURNAL OF HEPATOLOGY
- 955 PRECLINICAL POTENCY, PHARMACOKINETIC AND ADME CHARACTERIZATION OF ABT-333, A NOVEL NON-NUCLEOSIDE HCV POLYMERASE INHIBITOR
- (2009) C. Maring et al. JOURNAL OF HEPATOLOGY
- Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
- (2009) Mari M. Kitahata et al. NEW ENGLAND JOURNAL OF MEDICINE
- Transplantation in the patient with hepatitis C
- (2009) Beatriz Domínguez-Gil et al. TRANSPLANT INTERNATIONAL
- Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patients
- (2008) Thomas Kuntzen et al. HEPATOLOGY
- Natural Prevalence of Hepatitis C Virus Variants with Decreased Sensitivity to NS3·4A Protease Inhibitors in Treatment‐Naive Subjects
- (2008) Doug J. Bartels et al. JOURNAL OF INFECTIOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now